By Philippe Gire & Louisa Mesnard As Ornikar announces a new round of funding, we figured it was the right time to look back on how they mastered the art of disruption these past 7 years and to share some insights about their astonishing execution. Let’s start by defining the…

What are the next hot topics? This multi billion dollar question is on everybody’s lips ; experts’ opinions vary. Our crystal ball at Elaia is not more accurate than others, but we spent a lot of time analyzing the main technological trends and market forces to try figuring it out. …

As for everyone else, this troubled period has been intense at Elaia. However, we feel very lucky to have been able to keep working with awesome entrepreneurs and close a good number of great deals. …

This article is based on a series of talks and interviews with Xavier Lazarus, managing partner at Elaia, which were given during the lockdown period. May 2020. The number of daily Covid-19 deaths seems to be flattening. Most countries have gone out of lockdown. Sometimes we even want to believe…

Biotech is one of the strangest, sexiest and scariest industries in the world! Story written by Franck Lescure & Louisa Mesnard Biotech is often associated with a dark and incomprehensible world that only experts know about. That’s why, Franck Lescure, our Life Sciences Partner, joined us at Elaia in 2018. …

Fretlink just announced a major round of investment of €25m so we figured now was a good time to flashback on why we believe in this awesome company! 🚚 Looking for a player disrupting the shipping market Back in March 2017, we had been looking at the trucking industry for…

We are delighted to announce our investment in SeqOne, one of the sexiest cloud-based biotech companies! 💥 The right treatment at the right time 💥 Based in Montpellier, SeqOne was cofounded by two childhood friends, Nicolas Philippe and Guillaume Buwalda, who imagined a better way to analyse genomic data in healthcare. With support from the Montpellier University Hospital (CHRU…

Actual performance is very secretive in Venture Capital, and Private Equity, generally speaking. Some would say that it’s a confidential matter between a fund and its investors, others that the concept itself is void because when you compute it, most of the portfolios are unrealized and the hardest critics just…

This past week, both Mirakl and Shift Technology have announced major investment rounds. We, at Elaia, figured it was a good time to share how proud we are of their trip from seed to Series C! We are super impressed by both of these amazing teams, how they have managed…